Evidence map›Paper›PMID 33195417›Full record

ReviewFrontiers in molecular biosciences2020

Metabolic Alterations in

Yiqu Cao, Yun Peng, Ha Eun Kong, Emily G Allen, Peng Jin

Abstract readReview
In one paragraph

Review in Frontiers in molecular biosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yiqu CaoDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA, United States.
Yun PengDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA, United States.
Ha Eun KongDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA, United States.
Emily G AllenDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA, United States.
Peng JinDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA, United States.

Funding

Preclinical and Clincial OutcomesP50HD103555 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI Sandesh Chakravarthy Sreenath Nagamani, David Loren Nelson · 2020 to 2026
$9.9M
Molecular Basis of rCGG-Mediated NeurodegenerationR01NS051630 · NINDS · EMORY UNIVERSITY · PI NELSON, DAVID LOREN · 2006 to 2023
$9.8M
Recruitment CoreU54NS091859 · NINDS · EMORY UNIVERSITY · PI WARREN, STEPHEN T. · 2014 to 2019
$9.1M
Dynamic DNA Modifications in Brain and DiseasesR35NS111602 · NINDS · EMORY UNIVERSITY · PI PENG JIN · 2019 to 2026
$6.5M
Metabolic Dysregulation in FXTAS PathogenesisR21AG065815 · NIA · EMORY UNIVERSITY · PI ALLEN, EMILY GRAVES, NELSON, DAVID LOREN · 2020 to 2021
$448k
NIA NIH HHS R21 AG065815NICHD NIH HHS P50 HD103555NINDS NIH HHS R01 NS051630NINDS NIH HHS R35 NS111602NINDS NIH HHS U54 NS091859
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerFMR1FXTASmetabolomicstherapeutic development

Identifiers

PMID33195417
PMCPMC7531624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.